BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

432 related articles for article (PubMed ID: 26970136)

  • 1. Cancer prevention in HIV-infected populations.
    Goncalves PH; Montezuma-Rusca JM; Yarchoan R; Uldrick TS
    Semin Oncol; 2016 Feb; 43(1):173-188. PubMed ID: 26970136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of human papillomavirus (HPV)-related tumors in people living with human immunodeficiency virus (HIV).
    Poljak M; Šterbenc A; Lunar MM
    Expert Rev Anti Infect Ther; 2017 Nov; 15(11):987-999. PubMed ID: 29027811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Malignancy Trends in HIV-Infected Patients Over the Past 10 Years in a Single-Center Retrospective Observational Study in the United States.
    Rihana N; Nanjappa S; Sullivan C; Velez AP; Tienchai N; Greene JN
    Cancer Control; 2018; 25(1):1073274818797955. PubMed ID: 30185062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HPV-Associated Anal Cancer in the HIV/AIDS Patient.
    Wang CJ; Palefsky JM
    Cancer Treat Res; 2019; 177():183-209. PubMed ID: 30523625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AIDS-Associated Malignancies.
    Vangipuram R; Tyring SK
    Cancer Treat Res; 2019; 177():1-21. PubMed ID: 30523619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human papillomavirus-related malignancies in HIV infection: anal and oropharyngeal cancers.
    Wilkin TJ
    Top Antivir Med; 2018 Sep; 26(3):85-88. PubMed ID: 30384331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genital Epstein Barr Virus is associated with higher prevalence and persistence of anal human papillomavirus in HIV-infected men on antiretroviral therapy.
    Gianella S; Ginocchio CC; Daar ES; Dube MP; Morris SR
    BMC Infect Dis; 2016 Jan; 16():24. PubMed ID: 26809559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and risk factors for oral DNA tumor viruses in HIV-infected youth.
    Kahn JA; Rudy BJ; Xu J; Kapogiannis B; Secord E; Gillison M
    J Med Virol; 2016 Nov; 88(11):1944-52. PubMed ID: 27096166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced hepatitis B virus (HBV)-specific CD4+ T-cell responses in human immunodeficiency virus type 1-HBV-coinfected individuals receiving HBV-active antiretroviral therapy.
    Chang JJ; Wightman F; Bartholomeusz A; Ayres A; Kent SJ; Sasadeusz J; Lewin SR
    J Virol; 2005 Mar; 79(5):3038-51. PubMed ID: 15709024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human immunodeficiency virus (HIV) and Epstein-Barr virus (EBV) related lymphomas, pathology view point.
    Linke-Serinsöz E; Fend F; Quintanilla-Martinez L
    Semin Diagn Pathol; 2017 Jul; 34(4):352-363. PubMed ID: 28506687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Viral infections associated with oral cancers and diseases in the context of HIV: a workshop report.
    Speicher DJ; Ramirez-Amador V; Dittmer DP; Webster-Cyriaque J; Goodman MT; Moscicki AB
    Oral Dis; 2016 Apr; 22 Suppl 1(Suppl 1):181-92. PubMed ID: 27109286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human papillomavirus-related oropharyngeal cancer in the HIV-infected population.
    Wang CC; Palefsky JM
    Oral Dis; 2016 Apr; 22 Suppl 1():98-106. PubMed ID: 27109278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interest of cytology combined with Xpert
    Nassereddine H; Charpentier C; Bucau M; Joly V; Bienvenu L; Davitian C; Abramowitz L; Benabderrahmane D; Kotelevets L; Chastre E; Lehy T; Walker F
    HIV Med; 2018 Nov; 19(10):698-707. PubMed ID: 30062761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [HIV-associated tumors].
    Potthoff A; Brockmeyer NH
    Hautarzt; 2006 Nov; 57(11):988, 990-3. PubMed ID: 17036250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV-associated lymphoma in the era of combination antiretroviral therapy: shifting the immunological landscape.
    Carroll V; Garzino-Demo A
    Pathog Dis; 2015 Oct; 73(7):. PubMed ID: 26121984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The growing problem of non-AIDS-defining malignancies in HIV.
    Pantanowitz L; Schlecht HP; Dezube BJ
    Curr Opin Oncol; 2006 Sep; 18(5):469-78. PubMed ID: 16894295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Viruses and cancer.
    Hernandez B; Shiramizu B
    Hawaii Med J; 2005 Apr; 64(4):106-8. PubMed ID: 15921249
    [No Abstract]   [Full Text] [Related]  

  • 18. Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy.
    Clifford GM; Polesel J; Rickenbach M; Dal Maso L; Keiser O; Kofler A; Rapiti E; Levi F; Jundt G; Fisch T; Bordoni A; De Weck D; Franceschi S;
    J Natl Cancer Inst; 2005 Mar; 97(6):425-32. PubMed ID: 15770006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trends in Malignancies among Korean Patients Infected with Human Immunodeficiency Virus in the Highly Active Antiretroviral Therapy Era.
    Lee S; Lee SH; Lee JE; Kang JS; Lee SG; Chung JS; Kwak IS
    J Korean Med Sci; 2017 Sep; 32(9):1445-1450. PubMed ID: 28776339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human papillomavirus-related tumors in HIV.
    Palefsky J
    Curr Opin Oncol; 2006 Sep; 18(5):463-8. PubMed ID: 16894294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.